About the VHIR
Here at the Vall d'Hebron Research Institute (VHIR) we promote biomedical research, innovation and teaching. Over 1,800 people are seeking to understand diseases today so the treatment can be improved tomorrow.
Research
We are working to understand diseases, to find out how they operate and to create better treatments for patients. Get to know about our groups and their lines of research.
People
People are the centre of the Vall d'Hebron Research Institute (VHIR). This is why we are bound by the principles of freedom of research, gender equality and professional attitudes that HRS4R promotes.
Clinical trials
Our work is not just basic or translational; we are leaders in clinical research. Enter and find about the clinical trials we are conducting and why we are a world reference in this field.
Progress
Our aim is to make the research carried out at the Vall d’Hebron Research Institute (VHIR) a driving force for transformation. How? By identifying new channels and solutions for the promotion of people's health and well-being.
Core facilities
We offer specialist support for researchers, internal and external alike, ranging from specific services to preparing complete projects. All this, from a perspective of quality and speed of response.
News
We offer you a gateway for staying up to date on everything going on at the Vall d’Hebron Research Institute (VHIR), from the latest news to future solidarity activities and initiatives that we are organising.
Cardiovascular Diseases group is a translational research group within the Cardiology Department of Vall d’Hebron Hospital that performs laboratory, clinical and epidemiological research. In the CIBERCV network we are within the topic of descriptor 2 “Arterial disease, thrombosis and myocardial ischemia-reperfusion injury”. Our contributions in these topics address the following lines:
In the CIBERESP network, our group is interested in the study of effectiveness/cost-effectiveness of cardiovascular interventions, health outcome research and methods in clinical research. The group has 19 principal investigators, 32 active projects and clinical trial and has been done 142 publications in 2020.
PMID: 34929463 Journal: COMPUTERS IN BIOLOGY AND MEDICINE Year: 2022 Reference: Comput Biol Med. 2022 Feb;141:105147. doi: 10.1016/j.compbiomed.2021.105147. Epub 2021 Dec 16. Impact factor: 4.589 Publication type: Paper in international publication Authors: Franco, Pamela, Sotelo, Julio, Guala, Andrea, Dux-Santoy, Lydia, Evangelista, Arturo, Rodriguez-Palomares, Jose, Mery, Domingo, Uribe, Sergio, Salas, Rodrigo et al. DOI: 10.1016/j.compbiomed.2021.105147
PMID: 33576384 Journal: CARDIOVASCULAR RESEARCH Year: 2022 Reference: Cardiovasc Res. 2022 Jan 29;118(2):440-460. doi: 10.1093/cvr/cvab035. Impact factor: 10.787 Publication type: Paper in international publication Authors: Li, Xixiao, Garcia-Elias, Anna, Benito, Begona, Nattel, Stanley et al. DOI: 10.1093/cvr/cvab035
PMID: 35086653 Journal: JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY Year: 2022 Reference: J Am Coll Cardiol. 2022 Feb 1;79(4):324-326. doi: 10.1016/j.jacc.2021.11.037. Impact factor: 24.093 Publication type: Editorail in international publication Authors: Barrabes, Jose A, Soriano-Colome, Toni, Ferreira-Gonzalez, Ignacio et al. DOI: 10.1016/j.jacc.2021.11.037
PMID: 35054153 Journal: Journal of Clinical Medicine Year: 2022 Reference: J Clin Med. 2022 Jan 17;11(2). pii: jcm11020456. doi: 10.3390/jcm11020456. Impact factor: 4.242 Publication type: Review in international publication Authors: Evangelista Masip, Arturo, Galian-Gay, Laura, Guala, Andrea, Lopez-Sainz, Angela, Teixido-Tura, Gisela, Ruiz Munoz, Aroa, Valente, Filipa, Gutierrez, Laura, Fernandez-Galera, Ruben, Casas, Guillem et al. DOI: 10.3390/jcm11020456
PMID: 33977309 Journal: EUROPEAN RADIOLOGY Year: 2021 Reference: Eur Radiol. 2021 Dec;31(12):9262-9272. doi: 10.1007/s00330-021-08016-3. Epub 2021 May 12. Impact factor: 5.315 Publication type: Paper in international publication Authors: Rodriguez-Palomares, Jose F, Ferreira-Gonzalez, Ignacio, Guala, Andrea, Evangelista, Arturo, Teixido-Tura, Gisela, Dux-Santoy, Lydia, Ruiz-Munoz, Aroa, Valente, Filipa, Galian-Gay, Laura, Gutierrez, Laura et al. DOI: 10.1007/s00330-021-08016-3
PMID: 33892507 Journal: CARDIOVASCULAR RESEARCH Year: 2021 Reference: Cardiovasc Res. 2021 Jul 27;117(9):2045-2053. doi: 10.1093/cvr/cvab144. Impact factor: 10.787 Publication type: Review in international publication Authors: Mazzolai, Lucia, Alatri, Adriano, Riviere, Alessandra Bura, De Carlo, Marco, Heiss, Christian, Espinola-Klein, Christine, Schlager, Oliver, Sillesen, Henrik, Staub, Daniel, Palomares, Jose R et al. DOI: 10.1093/cvr/cvab144
PMID: 33303044 Journal: CARDIOLOGY IN THE YOUNG Year: 2021 Reference: Cardiol Young. 2021 Apr;31(4):671-672. doi: 10.1017/S1047951120004539. Epub 2020 Dec 11. Impact factor: 1.093 Publication type: Letter or abstract Authors: Figueras-Coll, Marc, Betrian-Blasco, Pedro, Marti-Aguasca, Gerard et al. DOI: 10.1017/S1047951120004539
PMID: 33865791 Journal: JACC-Cardiovascular Imaging Year: 2021 Reference: JACC Cardiovasc Imaging. 2021 Jun;14(6):1127-1129. doi: 10.1016/j.jcmg.2021.02.016. Epub 2021 Apr 14. Impact factor: 14.805 Publication type: Editorail in international publication Authors: Evangelista, Artur et al. DOI: 10.1016/j.jcmg.2021.02.016
PMID: 31377144 Journal: REVISTA ESPANOLA DE CARDIOLOGIA Year: 2020 Reference: Rev Esp Cardiol (Engl Ed). 2020 Jan;73(1):89-90. doi: 10.1016/j.rec.2019.06.005. Epub 2019 Jul 31. Impact factor: 4.642 Publication type: Letter whit IF Authors: Guala, Andrea, Dux-Santoy, Lydia, Teixido-Tura, Gisela, Johnson, Kevin M, Evangelista, Arturo, Rodriguez-Palomares, Jose et al. DOI: 10.1016/j.recesp.2019.06.018
PMID: 31801375 Journal: ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY Year: 2020 Reference: Arterioscler Thromb Vasc Biol. 2020 Jan;40(1):e10-e20. doi: 10.1161/ATVBAHA.119.313636. Epub 2019 Dec 5. Impact factor: 6.604 Publication type: Paper in international publication Authors: Ferreira, Ignacio, Evangelista, Arturo, Rodriguez-Palomares, Jose F, Wieben, Oliver, Johnson, Kevin M, Gutierrez, Laura, Dux-Santoy, Lydia, Guala, Andrea, Sotelo, Julio, Uribe, Sergio et al. DOI: 10.1161/ATVBAHA.119.313636
The consensus document is the result of multidisciplinary work that takes into account the risks associated with all stages of women's lives and the differences compared to men.
The study, which involved Vall d'Hebron, developed an action plan to efficiently allocate resources to patients most at risk of suffering this complication.
In light of this evidence, hospitals such as Vall d'Hebron have already started to include warnings about environmental pollution in their hospital discharge plans after a myocardial infarction.
